Just like the novel coronavirus itself, the emergence of so-called long COVID has surprised both the patients who couldn’t shake their symptoms and the clinicians who have struggled to provide effective treatments. Now, as the U.S. looks to move past the pandemic, there remain unanswered questions about how this fallout from the virus might hamper some workers and for how long. These uncertainties could have important implications for workers’ compensation. By some measures, one in four patients who get COVID-19—even those with mild or asymptomatic cases—will experience subsequent symptoms that range from muscle and nerve pain to breathing difficulties to anxiety and depression. The scope of the challenge will require providers and employers to better understand the nature of the conditions, their origins, and the best paths for treatment. Watch this on-demand webinar to learn more about long COVID and the implications for workers and employers.
More stories
Workers' Comp
Article
What's in Your Medicine Cabinet?
How many of us have medicine cabinets where we store our “you never know” items?
PC 360
Article
The Complex Landscape Surrounding High-Impact Drugs & Workers' Comp
While high costs and other challenges remain a concern, specialty drugs including biologics and biosimilars should be continually evaluated for pot
Mitchell
News Release
Mitchell Awarded Third Patent for Collision Repair Diagnostics
Company continues to add to its growing portfolio of issued U.S.
Risk & Insurance
In the News
P&C Update: Auto Liability and Workers’ Comp Could See a Tidal Wave of Change in 2023
Auto Physical Damage
News Release
Mitchell Diagnostics Reaches New Milestone for Dynamic and Static Calibrations
Latest achievement driven by increasing vehicle complexity and growing reliance on the company's ADAS calibration target system
Business Insurance
In the News